The problem is that this is not the only trial in the same population
I'll bite. What is the other trial or trials in the same population?
You mean MSB maybe?
From my point of view this is still just a potential trial from CYPs standpoint. They haven't committed to doing it yet. There are things that have to be done to create the option of going ahead. But those things fall short of formal commitment to beginning. As is MSBs adult trial either before or after BLA resubmission.
I'm not even taking it - CYPs phase 2 appearing on the clinicaltrials website with a date of 9 December if I recall correctly particularly seriously in terms of reading the protocol closely because I'm giving CYP credit for not being stupid. For having learned. I'm investing a little hope in the professionalism of Jolanta.
I think its wise for CYP to have an expected starting date of March next year without a committed starting date of March next year.
- Forums
- ASX - By Stock
- Going forward...
CYP
cynata therapeutics limited
Add to My Watchlist
9.68%
!
17.0¢

The problem is that this is not the only trial in the same...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
0.015(9.68%) |
Mkt cap ! $38.41M |
Open | High | Low | Value | Volume |
15.5¢ | 17.0¢ | 15.5¢ | $47.10K | 289.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 23813 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.165 |
4 | 47240 | 0.155 |
4 | 161673 | 0.150 |
1 | 5000 | 0.145 |
2 | 45000 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 18813 | 2 |
0.175 | 55250 | 1 |
0.180 | 62619 | 3 |
0.185 | 35990 | 1 |
0.195 | 19300 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online